- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.11 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 0LI: 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzam ide(Non-covalent)
- 16 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 4 residues within 4Å:- Chain A: R.278, P.279, S.280, R.283
Ligand excluded by PLIPSO4.3: 3 residues within 4Å:- Chain A: P.260, K.261, R.262
Ligand excluded by PLIPSO4.4: 2 residues within 4Å:- Chain A: K.272, K.273
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain A: R.36, G.38, S.39
Ligand excluded by PLIPSO4.6: 5 residues within 4Å:- Chain A: R.36, S.39, T.44, Y.46, N.60
Ligand excluded by PLIPSO4.7: 4 residues within 4Å:- Chain A: E.123, M.124, R.256, N.258
Ligand excluded by PLIPSO4.8: 8 residues within 4Å:- Chain A: V.85, T.163, K.165
- Chain B: Q.104, H.159, T.163, K.165
- Ligands: SO4.20
Ligand excluded by PLIPSO4.9: 5 residues within 4Å:- Chain A: W.24, R.80
- Chain B: W.24, R.80
- Ligands: SO4.21
Ligand excluded by PLIPSO4.14: 4 residues within 4Å:- Chain B: R.278, P.279, S.280, R.283
Ligand excluded by PLIPSO4.15: 3 residues within 4Å:- Chain B: P.260, K.261, R.262
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain B: K.272, K.273
Ligand excluded by PLIPSO4.17: 3 residues within 4Å:- Chain B: R.36, G.38, S.39
Ligand excluded by PLIPSO4.18: 5 residues within 4Å:- Chain B: R.36, S.39, T.44, Y.46, N.60
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain B: E.123, M.124, R.256, N.258
Ligand excluded by PLIPSO4.20: 8 residues within 4Å:- Chain A: Q.104, H.159, T.163, K.165
- Chain B: V.85, T.163, K.165
- Ligands: SO4.8
Ligand excluded by PLIPSO4.21: 5 residues within 4Å:- Chain A: W.24, R.80
- Chain B: W.24, R.80
- Ligands: SO4.9
Ligand excluded by PLIP- 2 x NH4: AMMONIUM ION(Non-functional Binders)
NH4.10: 5 residues within 4Å:- Chain A: G.108, S.109, H.114, L.158, D.161
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.109, A:S.109, A:D.161
NH4.22: 5 residues within 4Å:- Chain B: G.108, S.109, H.114, L.158, D.161
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:S.109, B:L.158, B:D.161, B:D.161
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.11: 5 residues within 4Å:- Chain A: L.115, H.116, G.226, Q.227, L.228
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:L.115, A:L.228
EDO.12: 5 residues within 4Å:- Chain A: D.139, P.282, L.285, A.286
- Chain B: H.51
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:H.51, A:A.286
EDO.23: 5 residues within 4Å:- Chain B: L.115, H.116, G.226, Q.227, L.228
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:L.115, B:H.116, B:L.228
EDO.24: 5 residues within 4Å:- Chain A: H.51
- Chain B: D.139, P.282, L.285, A.286
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:D.139, B:A.286, A:H.51
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cotto-Rios, X.M. et al., Inhibitors of BRAF dimers using an allosteric site. Nat Commun (2020)
- Release Date
- 2020-09-23
- Peptides
- Serine/threonine-protein kinase B-raf: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.11 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 0LI: 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzam ide(Non-covalent)
- 16 x SO4: SULFATE ION(Non-functional Binders)
- 2 x NH4: AMMONIUM ION(Non-functional Binders)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cotto-Rios, X.M. et al., Inhibitors of BRAF dimers using an allosteric site. Nat Commun (2020)
- Release Date
- 2020-09-23
- Peptides
- Serine/threonine-protein kinase B-raf: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A